ArticleAntimicrobial agents and chemotherapy2015

In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.

Steffen Wildum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.